✦ LIBER ✦

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010

✍ Scribed by Nava, F.; Tramacere, I.; Fittipaldo, A.; Bruzzone, M. G.; DiMeco, F.; Fariselli, L.; Finocchiaro, G.; Pollo, B.; Salmaggi, A.; Silvani, A.; Farinotti, M.; Filippini, G.

Book ID: 121479610
Publisher: Duke University Press
Year: 2014
Tongue: English
Weight: 236 KB
Volume: 16
Category: Article
ISSN: 1522-8517
DOI: 10.1093/neuonc/not316

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB